title: Vancomycin-associated leukocytoclastic vasculitis.
abstract: Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published. We report on a patient who developed pruritus and palpable purpura in both lower extremities after receiving six days of intravenous vancomycin. Skin biopsy revealed leukocytoclastic vasculitis.
authors.affiliation: Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.
authors.forename: Makhawadee
authors.initials: M
authors.lastname: Pongruangporn
authors.forename: David J
authors.initials: DJ
authors.lastname: Ritchie
authors.forename: Dongsi
authors.initials: D
authors.lastname: Lu
authors.forename: Jonas
authors.initials: J
authors.lastname: Marschall